BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 9, 2022
View Archived Issues
Discovery of GB-1101, selective oral HDAC6 inhibitor with potent antitumor activity in vivo
Read More
Gannex Pharma presents new FXR agonists
Read More
Novel biomarkers for identifying progression of diabetic retinopathy
Read More
XuanZhu Pharma divulges AhR antagonists
Read More
Gasherbrum Bio identifies new GLP-1 receptor agonists
Read More
New PADI4 inhibitors disclosed by Helios-Huaming BioPharma
Read More
Jiangsu Simcere Pharmaceutical synthesizes new Mat2A inhibitors
Read More
Celgene ERK/NLK inhibitor CC-91516 shows activity against BRAF and CTNNB1 mutant tumors
Read More
Targeting NR2E3 is a potential approach to avoid photoreceptor degeneration in retinitis pigmentosa
Read More
Proline links gut microbiome to depression
Read More
Novel variant in the DHX38 gene tied to congenital dyserythropoietic anemia with ring sideroblasts
Read More
Studies identify genetic risk factors for hyperemesis gravidarum and recurrence
Read More
AGEN-1571 reverses ILT-2-mediated immunosuppression to activate antitumor immunity
Read More
